Whitepaper: Liposomes in the Treatment of Neurological Trauma and Degeneration
Every treatment in medicine requires a delivery method. Pills, capsules, creams, patches, intravenous, injections, and other long-used delivery systems all have advantages and disadvantages. In some cases, the delivery method can influence how effective a drug is, and the likelihood it will cause side effects. When it comes to neurological inflammation and degeneration, both medication and effective delivery methods are lacking.
As the American population’s average age is the oldest it’s ever been, degenerative neurological conditions, such as Alzheimer’s or Parkinson’s disease, are becoming more common. Modern medicine has few answers for these diseases, and the drug model currently dominating medical intervention strategies is not well-suited to treating most neurological conditions.
The cutting edge of research around neurologic inflammation is highly suggestive that a multifactorial, nutritionally supportive approach to the treatment of neurological degeneration has the best long-term potential. An emerging delivery method using liposomes has clinicians excited for a future of targeted, effective treatments with minimal side effects.
Kenneth Proefrock, NMD, has extensive experience in preparing liposomal therapies for his naturopath practice in Arizona. Through the lens of treating neuroinflammation, Proefrock explains the science behind the liposomal treatment delivery method, the current challenges to clinicians looking for true liposomal products in the supplement market, and the potential for effective neurological treatment in the future.
Thank you for downloading!